MarketsandMarkets is providing a platform for pharmaceutical, biotechnology professionals and technology providers to come together at the BioGeNe 2022 Confex on the 16th - 17th June 2022 in San Diego-USA to discuss advancements and solutions to the most critical challenges in the Biomarker, Microbiome and Genome engineering areas.
With growing pressures of increasing success rates for FDA approved biomarkers as well as companion diagnostics tests has seen an outgrowth in drug discovery companies to invest in novel strategies for biomarker discovery. The industry of genome editing has witnessed some great breakthroughs during a year in the areas like genome writing, base editing and specific progression in the field of therapeutics through the Car-T cells and immunotherapy. With the increasing focus on the development of human microbiome therapies and probiotics product &drug development various small innovative players are operating in the market.
Witness an overwhelming participation of the key decision makers from academia, pharmaceutical and bio-pharmaceutical industies working in the areas of research and development, manufacturing, market access, commercialization and supply chain under one roof.
MarketsandMarkets’ Biopharma Series is a platform providing an opportunity to experts from the industry, regulators, academia and technology providers to discuss innovations, challenges, best practices, use-cases and future aspects in the area of single cell analysis, next-gen immune-oncology, next-gen bioprocessing, cell and gene therapy manufacturing, biosimilars drug development and commercialization and pharma supply chain and logistics.